The minimally invasive procedure was performed as part of a clinical trial, according to a March 7 news release from the hospital. The procedure is used to treat tricuspid regurgitation, which affects an estimated 1.6 million Americans.
The valve is replaced by inserting a catheter through the major vein of the leg. The procedure was performed by Gagan Singh, MD, who will monitor patients participating in the TTVR clinical trial for five years.
